ArticleAmerican journal of speech-language pathology2025
Simplified Vocal Efficiency Metrics Normalize Following Voice Therapy in Subgroups of Patients With Nonphonotraumatic Vocal Hyperfunction.
Article in American journal of speech-language pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Simplified Vocal Efficiency Metrics Normalize Following Voice Therapy in Subgroups of Patients With Nonphonotraumatic Vocal Hyperfunction.American journal of speech-language pathology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeThe purpose of this study is to determine whether simplified vocal efficiency (VE) metrics could accurately identify changes after voice therapy in individuals with nonphonotraumatic vocal hyperfunction (NPVH). This study analyzes treatment-related changes for traditional VE-vocal intensity (square of sound pressure) over aerodynamic power-and three simplified VE ratios: (a) sound pressure level over aerodynamic power (SPL/AP), (b) SPL over subglottal pressure (SPL/Ps), and (c) SPL over airflow (SPL/AFLOW).
methodRetrospective data from 108 adults (80 females, 28 males) diagnosed with primary muscle tension dysphonia (associated with NPVH) and 208 vocally healthy adults (181 females, 27 males). Study participants produced repeated consonant-vowel utterances in comfortable and loud conditions before and after voice therapy, with acoustic SPL and aerodynamic measurements (Ps and AFLOW) derived. Pre- to posttherapy VE changes were analyzed using mixed-design analysis of variance models. In an exploratory analysis, patients were divided into three subgroups based on their pretherapy VE measures to investigate treatment effects within NPVH subgroups.
resultsPre- to posttherapy VE changes were not observed for the NPVH group as a whole. A subsequent subgroup analysis revealed treatment effects within female patients with NPVH exhibiting lower and higher than typical pretherapy VE metrics. SPL/Ps exhibited a treatment effect in both loudness conditions and migration toward normative ranges following therapy. Posttherapy changes were observed to varying degrees in both loudness conditions for traditional VE and simplified VE metrics of SPL/AP and SPL/AFLOW.
conclusionsVE ratios, especially SPL/Ps, demonstrate potential as metrics for evaluating the outcome of voice therapy in individuals with NPVH and aid in stratifying individuals with NPVH into subgroups compared to vocally healthy values. Further investigations are warranted to investigate the role of VE metrics in the assessment, treatment, and prevention of NPVH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.